| Also known as |
Arimistane |
| Blood pressure |
Can potentially increase if water retention occurs |
| Chemical name |
Androsta-3,5-diene-7,17-dione |
| Dosage (medical) |
Not typically used for medical purposes |
| Dosage (sports) |
50-75 mg per day |
| Effects |
Increased testosterone levels, decreased estrogen levels |
| Formula |
C19H24O2 |
| Half-life |
48 hours |
| Hepatotoxicity |
Low |
| Lab Test |
Testosterone and estrogen levels, liver function tests |
| Main action |
Inhibition of aromatase enzyme, reducing estrogen synthesis |
| Side effects |
Potential hormonal imbalances, risk of joint discomfort, and potential impact on lipid profiles |
| Storage conditions |
Store in a cool, dry place, away from light |
| Substance class |
Steroidal aromatase inhibitor |
| Trade name |
Not commercially available as a medication |
| Use in sports |
Used as an ancillary compound to manage estrogen levels in anabolic steroid cycles |
| Water Retention |
Low |
| Release form |
caps |
| Manufacturer |
Apocalypse Labz |
| Packing |
60 caps |
